Reserpine,Hydralazine Hydrochloride,and Hydrochlorothiazide Tablets
»Reserpine,Hydralazine Hydrochloride,and Hydrochlorothiazide Tablets contain not less than 90.0percent and not more than 110.0percent of the labeled amount of reserpine (C33H40N2O9),and not less than 93.0percent and not more than 107.0percent of the labeled amounts of hydralazine hydrochloride (C8H8N4·HCl)and hydrochlorothiazide (C7H8ClN3O4S2).
NOTE—Where Reserpine,Hydralazine Hydrochloride,and Hydrochlorothiazide Tablets are prescribed,without reference to the quantity of reserpine,hydralazine hydrochloride,or hydrochlorothiazide contained therein,a product containing 0.1mg of reserpine,25mg of hydralazine hydrochloride,and 15mg of hydrochlorothiazide shall be dispensed.
Packaging and storage— Preserve in tight,light-resistant containers.
Identification—
A: Transfer a quantity of finely powdered Tablets,equivalent to about 100mg of hydralazine hydrochloride,to a glass-stoppered flask.Add 40mLof dilute hydrochloric acid (1in 12),shake by mechanical means for 5minutes,and filter,discarding the first few mLof the filtrate.Transfer 20mLof the filtrate to a separator.Extract with a 10-mLportion of methylene chloride,and discard the methylene chloride.To the aqueous phase add 2mLof sodium nitrite solution (14in 1000)and 10mLof methylene chloride,and shake by mechanical means for 5minutes.Allow the layers to separate,and drain the methylene chloride through sodium sulfate that has been pre-washed with methylene chloride,into a 50-mLbeaker.Evaporate over gentle heat with the aid of nitrogen to dryness:the IRabsorption spectrum of a potassium bromide dispersion of the residue so obtained exhibits maxima only at the same wavelengths as that of a similar preparation of USP Hydralazine Hydrochloride RS,similarly treated (presence of hydralazine hydrochloride).
B: Transfer a quantity of finely powdered Tablets,equivalent to about 1mg of reserpine,to a 50-mLcentrifuge tube.Add 20mLof cyclohexane,shake by mechanical means for 15minutes,centrifuge,and discard the cyclohexane.Repeat the extraction with two additional 20-mLportions of cyclohexane,shaking by mechanical means for 2minutes each time.To the residue add 10mLof chloroform,shake for 2minutes,and filter through a medium-porosity,sintered-glass funnel into another 50-mLcentrifuge tube.Extract the chloroform with 10mLof 1.0Nhydrochloric acid,discarding the aqueous acid layer.Extract the chloroform with 10mLof 0.5Nsodium hydroxide.Centrifuge for 5minutes,and withdraw the chloroform with a syringe,passing the chloroform through cotton into a 50-mLvolumetric flask containing 40mLof methanol.Dilute with chloroform to volume,and mix:the UVabsorption spectrum of the solution so obtained exhibits maxima and minima at the same wavelengths as that of a similar solution of USP Reserpine RS,concomitantly measured (presence of reserpine).
C: The UVabsorption spectrum of the solution from the Assay preparation,obtained as directed for Procedurein the Assay for hydrochlorothiazide,exhibits maxima and minima at the same wavelengths as that of the solution from the Standard preparation,prepared as directed in the Assay for hydrochlorothiazide,similarly measured (presence of hydrochlorothiazide).
Uniformity of dosage units á905ñ: meet the requirements for Content Uniformitywith respect to reserpine,to hydralazine hydrochloride,and to hydrochlorothiazide.
Procedure for content uniformity—
Apparatus— Use an automatic analyzer consisting of (1)a solid sampler with 100-mLdissolution capability;(2)a 20-channel peristaltic pump;(3)a continuous filtering device;(4)a colorimeter equipped with a 2-mm flow cell and analysis capability at 530nm;(5)a UVspectrophotometer equipped with a 10-mm flow cell and analysis capability at 271nm;(6)a spectrofluorometer equipped with a 2-mm flow cell and analysis capability of 365nm activation energy and 495nm fluorescence;(7)recording devices for each of the three aforementioned detectors;and (8)a manifold consisting of components illustrated in the pertinent diagram in the chapter Automated Methods of Analysis á16ñ.Prepare the ion-exchange column listed in the manifold as follows.Wash sulfonic acid cation-exchange resin (40-to 60-mesh)with isopropyl alcohol until the alcohol shows no appreciable UVabsorption at 271nm,then add sufficient 1Nhydrochloric acid to cover the resin.Drain off the acid,and wash the resin with an equivalent volume of 1Nsodium hydroxide and then again with 1Nhydrochloric acid.Finally wash the resin with water until the effluent is neutral to litmus.Draw the resin into a 10-mm length of “solvaflex”tubing (1mm ID)by vacuum,and plug each end with glass wool.
Saturated vanadium pentoxide (V2O5)—Stir for about 6hours or shake by mechanical means for 2hours about 100mg of vanadium pentoxide powder with 100mLof phosphoric acid.Filter through a medium-porosity,sintered-glass funnel.This solution is stable for 1month.
0.3%Hydrogen peroxide (H2O2)—Dilute 1mLof 30percent hydrogen peroxide with water to 100mL.Prepare fresh daily.
Blue tetrazolium reagent (B.T.)—Dissolve 760mg of blue tetrazolium in 3.8liters of a mixture of dehydrated alcohol and methanol (19:1).
Tetramethylammonium hydroxide (T.M.A.H.)—Dilute 38mLof tetramethylammonium hydroxide solution (1in 10)with dehydrated alcohol and methanol (19:1)to 3.8liters.
Solvent,wash,anddiluent— Prepare by mixing equal volumes of methanol and water.Add 1mLof phosphoric acid to each 3.8liters.
Standard preparation— Accurately weigh about 42.0mg of USP Reserpine RSinto a 200-mLvolumetric flask,dissolve in methanol,and dilute with methanol to volume.Pipet 10mLof this solution into a 100-mLvolumetric flask containing about 315.0mg of USP Hydrochlorothiazide RSand about 525.0mg of USP Hydralazine Hydrochloride RS,accurately weighed.Dissolve in Solvent,and dilute with Solventto volume.(A5-mLaliquot represents 1standard Tablet.)
Procedure— With the sampler in the standby position,pump all reagents through the system until a stable baseline is achieved.Activate the sampler,and allow one cycle to pass without introducing the Tablets or the Standard preparation,then pipet a 5-mLaliquot of the Standard preparationinto the hopper at the solvent addition portion for the next two cycles and for every sixth cycle thereafter.Disregard the first value for the Standard preparation.Add the Tablets to the sampler at the rate of 20per hour to follow the second 5-mLaliquot of the Standard preparation.Record the absorbance and fluorescence values,and calculate each peak value by the difference between peak height and baseline.Calculate the quantity,in mg per Tablet,taken by the formula:
(0.005/1.05)C(AU/AS),
in which Cis the concentration,in µg per mL,of the appropriate Reference Standard in the Standard preparation,AUis the absorbance of the Tablet,and ASis the averaged absorbance of the Standard preparations.
Diazotizable substances—
Standard solution— Weigh accurately 25mg of USP Benzothiadiazine Related Compound A RS,dissolve in 5mLof methanol contained in a 50-mLvolumetric flask,dilute with water to volume,and mix.Pipet 4mLof this solution into a 100-mLvolumetric flask,dilute with water to volume,and mix.
Test solution— Transfer a portion of the powdered Tablets prepared for the Assay for hydrochlorothiazide,accurately weighed and equivalent to about 100mg of hydrochlorothiazide,to a 100-mLvolumetric flask,and add a mixture of 20mLof methanol and 20mLof water.Shake continuously for 5to 10minutes,dilute with water to volume,mix,and filter.Use the filtrate as the Test solution.
Procedure— Pipet 5mLeach of the Standard solutionand the Test solutioninto separate,50-mLvolumetric flasks.Pipet 5mLof water into a third 50-mLvolumetric flask to provide the blank.To each flask add 1mLof freshly prepared sodium nitrite solution (1in 100)and 5mLof dilute hydrochloric acid (1in 12),and allow to stand for 5minutes.Add 2mLof ammonium sulfamate solution (1in 50),allow to stand for 5minutes with frequent swirling,then add 2mLof freshly prepared disodium chromotropate solution (1in 100)and 10mLof sodium acetate TS.Dilute with water to volume,and mix.Concomitantly determine the absorbances of the solutions from the Standard solutionand the Test solutionin 1-cm cells at the wavelength of maximum absorbance at about 500nm,with a suitable spectrophotometer,against the blank.The absorbance of the solution from the Test solutiondoes not exceed that of the solution from the Standard solution,corresponding to not more than 2.0%of diazotizable substances.
Assay for reserpine—
Standard preparation— Dissolve about 25mg of USP Reserpine RS,accurately weighed,in chloroform in a 50-mLvolumetric flask,and dilute with chloroform to volume (Solution 1).Pipet 10mLof Solution 1into a 50-mLvolumetric flask,and dilute with chloroform to volume.Protect the solution from light.
Assay preparation— Weigh and finely powder not less than 20Tablets.Transfer an accurately weighed portion of the powder,equivalent to about 1mg of reserpine,to a separator or a stoppered,50-mLcentrifuge tube containing 10mLof citric acid solution (1in 50).Shake vigorously until the powder is completely suspended.Add 10mLof chloroform,and proceed as directed for Procedure,beginning with “shake thoroughly for 2minutes.”
Procedure— [NOTE—Conduct the entire procedure quickly,without exposure to direct sunlight.Perform the extractions in a suitable separator or in a suitably stoppered,50-mLcentrifuge tube,and separate by centrifuging,withdrawing the portion to be retained into a hypodermic syringe fitted with a square-tipped,14-gauge,15-cm needle.]Pipet 10mLof the Standard preparationinto the extraction vessel,add 10mLof citric acid solution (1in 50),and shake thoroughly for 2minutes.Separate and withdraw the chloroform.Wash the citric acid solution with two 10-mLportions of chloroform,adding the washings to the main chloroform solution.To the combined chloroform solutions add 10mLof citric acid solution (1in 50),shake for 2minutes,and separate and withdraw the chloroform.To the combined chloroform solutions add 10mLof sodium bicarbonate solution (1in 100),shake for 2minutes,and separate.Withdraw the chloroform,filtering it through a pledget of cotton,into a 50-mLvolumetric flask containing 14.0mLof methanol.Extract the aqueous bicarbonate layer in the extraction vessel with two 2-mLportions of chloroform,passing each portion successively through the filter into the volumetric flask.Add chloroform to volume,and mix.Pipet duplicate 5-mLaliquots of the chloroform-methanol solutions into separate,10-mLvolumetric flasks.Add 2.0mLof a 1in 10solution of hydrochloric acid in methanol to each flask.To one flask of each pair of duplicates (representing the extracted Standard preparationand the extracted Assay preparation)add 1.0mLof a 3in 1000solution of sodium nitrite in dilute methanol (1in 2).To the second flask of each pair (constituting the blanks)add 1mLof dilute methanol (1in 2).Mix,and allow to stand for 30minutes.Add 0.5mLof ammonium sulfamate solution (1in 20)to each flask,add methanol to volume,mix,and allow to stand for 10minutes.Determine the absorbance of each solution in a 1-cm cell at the wavelength of maximum absorbance at about 390nm,with a suitable spectrophotometer,relative to the absorbance of a mixture of methanol,chloroform,and water (5.4:3.6:1).
Calculate the quantity,in mg,of C33H40N2O9in the portion of Tablets taken by the formula:
0.01C(A-A0)U/(A-A0)S,
in which Cis the concentration,in µg per mL,of USP Reserpine RSin the Standard preparation,and the parenthetic expressions are the differences in absorbances of the nitrite-treated and blank solutions,respectively,from the Assay preparation(U)and the Standard preparation(S).
Assay for hydralazine hydrochloride—
Sodium acetate solution— Dissolve 27.2g of sodium acetate trihydrate in 50mLof water,bring to room temperature,and dilute with water to 100mL.
Ferric ammonium sulfate solution— Dissolve 1.8g of ferric ammonium sulfate in 4mLof dilute hydrochloric acid (1in 12),and dilute with water to 100mL.Filter,and use the clear filtrate.Prepare fresh.
1,10-Phenanthroline solution— Shake 300mg of 1,10-phenanthroline with 100mLof water for 1hour.Filter,and use the clear filtrate.Prepare fresh.
Standard preparation— Dissolve about 50mg of USP Hydralazine Hydrochloride RS,accurately weighed,in water in a 100-mLvolumetric flask,and dilute with water to volume.Pipet 10mLof this solution into a 100-mLvolumetric flask,dilute with water to volume,and mix.
Assay preparation— Weigh and finely powder not less than 20Tablets.Transfer to a 200-mLvolumetric flask an accurately weighed portion of the powder,equivalent to about 100mg of hydralazine hydrochloride,add 100mLof water,and shake by mechanical means for 30minutes.Dilute with water to volume,mix,and filter through paper,discarding the first 15mLof the filtrate.Pipet 10mLof the clear filtrate into a 100-mLvolumetric flask,and dilute with water to volume.
Procedure— Pipet 10mLeach of the Assay preparation,the Standard preparation,and water to provide the blank,into separate,200-mLvolumetric flasks.To each flask add 5mLof acetic acid solution (12in 100),5mLof Sodium acetate solution,2mLof 1,10-Phenanthroline solution,and 1mLof Ferric ammonium sulfate solution,mix,and allow to stand in the dark for 30minutes.Dilute with water to volume,and mix.Concomitantly determine the absorbances of both solutions in 1-cm cells at the wavelength of maximum absorbance at about 510nm,with a suitable spectrophotometer,against the blank.Calculate the quantity,in mg,of C8H8N4·HCl in the portion of Tablets taken by the formula:
2C(AU/AS),
in which Cis the concentration,in µg per mL,of USP Hydralazine Hydrochloride RSin the Standard preparation,and AUand ASare the absorbances of the solutions from the Assay preparationand the Standard preparation,respectively.
Assay for hydrochlorothiazide—
Methanolic sodium hydroxide solution— Dissolve 40g of sodium hydroxide in 125mLof water,cool,and dilute with methanol to 500mL.Filter before use.
Column preparation— Weigh about 10g of sulfonic acid cation exchange resin into a 250-mLbeaker.Add 75mLof methanol,and stir the mixture with a magnetic stirrer for 30minutes.Place a glass wool plug at the lower end of a glass chromatographic column (15mm ×45-cm long),equipped with a stopcock to regulate the eluant flow.Transfer and pack the slurry in portions into the prepared column to a height of 10cm.If air is trapped,remove by tapping,stirring,or back-flushing the column.Place a glass wool plug on top of the resin bed after packing.Wash the resin with consecutive 100-mLportions of a 1in 5solution of hydrochloric acid in methanol,and of methanol,then of Methanolic sodium hydroxide solutionand of methanol,respectively,using a flow rate of approximately 4mLper minute.Wash the sodium form of the resin with 150mLof a 1in 5solution of hydrochloric acid in methanol,followed by not less than 100mLof methanol.The UVspectrum of the last few mLof the methanol washing conforms to that of the methanol.
Standard preparation— Mix about 40mg of USP Hydrochlorothiazide RS,accurately weighed,with 4mLof water in a 200-mLvolumetric flask.Add 150mLof methanol,warm gently on a steam bath for a few minutes,and shake by mechanical means for 20minutes.Dilute with methanol to volume,and mix.
Assay preparation— Weigh and finely powder not less than 20Tablets.Transfer an accurately weighed portion of the powder,equivalent to about 20mg of hydrochlorothiazide,to a 100-mLvolumetric flask.Add 2mLof water,mix,and add 75mLof methanol.Warm gently on a steam bath for a few minutes,and shake by mechanical means for 20minutes.Dilute with methanol to volume,and mix.Centrifuge a portion of the mixture,and use the clear solution as the Assay preparation.
Procedure— Keeping the column stopcocks closed,pipet 4mLof the clear Assay preparationon the top of the resin bed of 1column,and pipet 4mLof the Standard preparationon the top of the second column.Place a 100-mLvolumetric flask beneath each of the columns,and collect the eluate.Adjust the flow rate to approximately 2mLper minute,and allow the solution to flow until it just disappears into the upper glass wool plug.Close the stopcock,carefully add 25mLof methanol,and further elute each column with the same flow rate as before.Repeat with two additional 25-mLportions of methanol.Dilute the contents of each flask with methanol to volume.Concomitantly determine the absorbances of both solutions at the wavelength of maximum absorbance at about 271nm,with a suitable spectrophotometer,using methanol as the blank.Calculate the quantity,in mg,of C7H8ClN3O4S2in the portion of Tablets taken by the formula:
0.1C(AU/AS),
in which Cis the concentration,in µg per mL,of USP Hydrochlorothiazide RSin the Standard preparation,and AUand ASare the absorbances of the solution from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Andrzej Wilk,Ph.D.,Senior Scientific Associate
Expert Committee:(PA5)Pharmaceutical Analysis 5
USP28–NF23Page 1716
Phone Number:1-301-816-8305